RADCOM (NASDAQ:RDCM – Get Free Report) was upgraded by stock analysts at Needham & Company LLC from a “hold” rating to a “buy” rating in a report issued on Thursday, Briefing.com reports. The brokerage currently has a $14.00 price target on the technology company’s stock. Needham & Company LLC’s price objective points to a potential […]
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its target price cut by Needham & Company LLC from $25.00 to $20.00 in a report released on Tuesday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on RVNC. Morgan Stanley reduced […]
Needham & Company LLC reissued their buy rating on shares of Taboola.com (NASDAQ:TBLA – Free Report) in a research report report published on Monday, Benzinga reports. They currently have a $5.00 price objective on the stock. Several other brokerages have also weighed in on TBLA. B. Riley upped their price objective on shares of Taboola.com […]
RxSight (NASDAQ:RXST – Free Report) had its price target raised by Needham & Company LLC from $35.00 to $41.00 in a report released on Monday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Other equities research analysts have also recently issued research reports about the stock. Stifel Nicolaus initiated […]
Needham & Company LLC reaffirmed their buy rating on shares of Credo Technology Group (NASDAQ:CRDO – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $24.00 target price on the stock. Several other brokerages have also recently weighed in on CRDO. TD Cowen boosted their price objective on […]